Clonazepam Tablet
Product Images NDC 70518-3849

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 70518-3849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Clonazepam 2 mg oral tablet label showing 100 tablets per box. The label displays the brand name ClonazePAM, controlled substance schedule C-IV, and is repackaged by RemedyRepack Inc. It includes an NDC number 70518-3849-00, manufacturer information (Aurobindo, India), storage instructions, and a caution about federal law restrictions.*
FDA Label Image

Mm2 (Clonazepam 2mg 70518 3849 01)

Mm2 (Clonazepam 2mg 70518 3849 01)
ClonazePAM 2 mg tablet packaging label from RemedyRepack Inc. The label indicates a single oral tablet quantity with Schedule IV classification (C-IV). It includes the NDC 70518-3849-01 and mentions the original manufacturer Aurobindo, India. The label also features usage directions pointing to the package insert and a barcode with a QR code.*
FDA Label Image

Chemical Structure (Clonazepam Str)

Chemical Structure (Clonazepam Str)
Chemical structure of Clonazepam, a benzodiazepine class compound. The structure includes a nitro-substituted benzodiazepine ring fused with a chlorophenyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.